Trial · NCT00082017
Adverse events146
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 146
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | abdominal pain | Gastrointestinal disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 4 | 20 | 5 |
| other | Activated partial thromboplastin time prolonged | Investigations | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 3 | 20 | 6 |
| other | Agitation | Psychiatric disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 1 | 20 | 1 |
| other | Alanine aminotransferase increased | Investigations | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 2 | 20 | 6 |
| other | Alkaline phosphatase increased | Investigations | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 3 | 20 | 3 |
| other | Allergic rhinitis | Immune system disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 1 | 20 | 1 |
| other | Anemia | Blood and lymphatic system disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 3 | 20 | 3 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 1 | 20 | 1 |
| other | Ascites | Gastrointestinal disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 1 | 20 | 1 |
| other | Aspartate aminotransferase increased | Investigations | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 4 | 20 | 8 |
| other | Back pain | Musculoskeletal and connective tissue disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 2 | 20 | 2 |
| other | Blood bilirubin increased | Investigations | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 2 | 20 | 6 |
| other | Bruising | Injury, poisoning and procedural complications | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 1 | 20 | 2 |
| other | Chest wall pain | Musculoskeletal and connective tissue disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 1 | 20 | 1 |
| other | Chills | General disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 5 | 20 | 7 |
| other | Colonic perforation | Gastrointestinal disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 1 | 20 | 1 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 2 | 20 | 2 |
| other | Creatinine increased | Investigations | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 3 | 20 | 3 |
| other | Diarrhea | Gastrointestinal disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 4 | 20 | 4 |
| other | Dizziness | Nervous system disorders | UCN-01 for T-cell Lymphomas - Cohort 1&2 | 1 | 20 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00082017/events